Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Goji Berries and Energy Expenditure

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
Sábháiltear an nasc chuig an gearrthaisce
StádasCríochnaithe
Urraitheoirí
Maastricht University Medical Center

Keywords

Coimriú

Effects of foods or food substances on energy expenditure are of particular interest, because of the increasing prevalence of obesity and its consequent metabolic diseases like type II diabetes and fatty liver disease, all risk factors for the development of cardiovascular diseases (CVDs). Recently, the Goji berry (Lycium Barbarum, wolfberry) was introduced into the Western diet. L. Barbarum originates from Asia, where it is used to improve the health of several organs. Although L. Barbarum is promoted as a super food with many beneficial effects, consistent scientific evidence for these effects is lacking. In one study, it was found that short-term intake of L. Barbarum polysaccharides - equal to 150 g of fresh berries - increased postprandial oxygen consumption. This indicates that L. Barbarum might exert beneficial effects on energy expenditure. Furthermore, long-term intervention trials have shown beneficial effects of L. Barbarum on lipid and glucose metabolism in mice and type II diabetic patients and on inflammatory status in healthy elderly. Altogether, L. Barbarum has the potential to be used as a functional food to increase metabolic health, but detailed information on the postprandial effects of L. Barbarum is missing. We therefore propose this double-blinded, randomized, placebo controlled intervention trial to investigate the effect of a single dose of L. Barbarum on postprandial energy expenditure substrate oxidation, metabolic flexibility, lipid and glucose metabolism and inflammatory markers.

Cur síos

Objectives:

The primary objective of this study is to investigate the effect of a single dose of L. Barbarum on postprandial energy expenditure. Secondary objectives are to investigate the effect of a single dose of L. Barbarum on postprandial lipid and carbohydrate oxidation and metabolic flexibility, on postprandial lipid and glucose metabolism and on inflammatory markers.

Study design:

This is a double blind, randomized, placebo-controlled intervention trial with two test days separated by a washout period of at least 1 week.

Study population:

The study population will consist of 20 apparently healthy overweight (BMI between 25 and 30 kg/m2) men aged 18-65 years.

Intervention:

All subjects will receive a mixed meal including 25 grams of dried L. Barbarum as the intervention product and a matched mixed meal without L. Barbarum as the placebo product. The meals will be matched for energy content and macronutrient composition.

Dátaí

Fíoraithe Deireanach: 03/31/2016
Cuireadh isteach den chéad uair: 04/17/2016
Clárú Measta Curtha isteach: 05/17/2016
Arna chur suas ar dtús: 05/22/2016
Nuashonrú Deireanach Curtha isteach: 01/30/2017
Nuashonrú Deireanach Postáilte: 01/31/2017
Dáta Tosaigh an Staidéir Iarbhír: 03/31/2016
Dáta Críochnaithe Bunscoile Measta: 11/30/2016
Dáta Críochnaithe an Staid Mheasta: 11/30/2016

Coinníoll nó galar

Overweight

Idirghabháil / cóireáil

Dietary Supplement: Lycium Barbarum mixed meal

Dietary Supplement: Control mixed meal

Céim

-

Grúpaí Láimhe

LámhIdirghabháil / cóireáil
Experimental: Lycium Barbarum mixed meal
Subjects will receive a high-fat mixed meal containing Lycium Barbarum once.
Dietary Supplement: Lycium Barbarum mixed meal
This mixed meal contains 25 grams of dried Lycium Barbarum (Goji berry, Wolfberry)
Active Comparator: Control mixed meal
Subjects will receive a high-fat mixed meal without Lycium Barbarum as a control.
Dietary Supplement: Control mixed meal
This mixed meal does not contain Lycium Barbarum, but is matched for energy and macronutrient content

Critéir Incháilitheachta

Aois Incháilithe le haghaidh Staidéir 18 Years Chun 18 Years
Gnéas Incháilithe le haghaidh StaidéirMale
Glacann Oibrithe Deonacha SláintiúlaSea
Critéir

Inclusion Criteria:

- Male gender

- BMI between 25 and 30 kg/m2

- Non-smoking

- Normal fasting triacylglycerol levels (<2.2 mmol/L)

- No hyperglycaemia or hypercholesterolemia (fasting glucose < 7.0 mmol/L and total cholesterol < 8.0 mmol/L)

- Willing to comply to the study protocol during the study

- Agreeing to be informed about medically relevant personal test-results

Exclusion Criteria:

- Use of anticoagulant medication

- Unstable body weight (weight gain or loss >3 kg in the past 3 months)

- Indications of treatment according to the Standard for Cardiovascular Risk Management from the Dutch General Practitioners community

- Any medical condition that might interfere with study measurements, judged by the principal investigator, including cardiovascular disease or events (e.g. acute myocardial infarction or cerebra-vascular accident), diabetes or hypercholesterolemia

- Use of any kind of medication or medically prescribed diet, which can interfere with the study (judged by the principal investigator). The use of paracetamol is allowed

- Use of oral antibiotics (with the exception of topical antibiotics) in 40 days or less prior to the start of the study

- Use of food supplements or plant-sterol/stanol-enriched foods or supplements in the three weeks prior to the screening and/or during the study

- Not willing to abstain from L. Barbarum consumption thee weeks before the start and during the trial

- Severe medical conditions that might interfere with the study, such as epilepsy, asthma, chronic obstructive pulmonary disease and rheumatoid arthritis

- Consumption of > 14 alcohol consumptions a week

- Reported intense sporting activities > 10 hours a week

- Abuse of drugs

- Participation in any other biomedical trial one month prior to the screening visit

- Having donated > 150 ml blood within 1 month prior to the screening visit, planning to donate blood during the study or within one month after finishing the study

- Impossible or difficult to puncture as evidenced during the screening visit

Toradh

Bearta Toraidh Príomhúla

1. Change from baseline energy expenditure [Measured as the incremental area under the curve (iAUC) from 0 minutes to 140 minutes after meal intake]

Energy expenditure will be measured using indirect calorimetry (ventilated hood system). This system measures oxygen consumption (VO2) and carbon dioxide production (VCO2) to calculate the energy expenditure (kJ/min)

Bearta Torthaí Tánaisteacha

1. Change from baseline energy expenditure [Measured as the incremental area under the curve (iAUC) from 160 minutes to 200 minutes and from 220 minutes to 260 minutes after meal intake]

Energy expenditure will be measured using indirect calorimetry (ventilated hood system). This system measures VO2 and VCO2 to calculate the energy expenditure (kJ/min).

2. Postprandial lipid and glucose oxidation [At baseline (T0, fasting) and between 0 minutes and 140 minutes, between 160 minutes and 200 minutes and between 220 minutes and 260 minutes after meal consumption]

Lipid and glucose oxidation will be calculated from indirect calorimetry data (VO2 and VCO2).

3. Metabolic flexibility [At 60, 120, 180 and 240 minutes after meal intake]

Metabolic flexibility will be derived from indirect calorimetry as the difference in respiratory quotient (RQ) between fasting and postprandial conditions.

4. Markers for lipid metabolism [At baseline (T0) and at regular intervals up to 240 minutes after meal consumption]

Several markers for lipid metabolism will be measured in blood samples.

5. Markers for glucose metabolism [At baseline (T0) and at regular intervals up to 240 minutes after meal consumption]

Several markers for glucose metabolism will be measured in blood samples.

6. Inflammatory status [At baseline (T0) and at 60, 120, 180 and 240 minutes after meal consumption]

Several markers for inflammatory status will be measured in blood samples and in vitro conditions

Bí ar ár
leathanach facebook

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht

  • Oibreacha i 55 teanga
  • Leigheasanna luibhe le tacaíocht ón eolaíocht
  • Aitheantas luibheanna de réir íomhá
  • Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
  • Léigh foilseacháin eolaíochta a bhaineann le do chuardach
  • Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
  • Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní

Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe

Google Play badgeApp Store badge